Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program
Author(s) -
Daniel Winetsky,
Daniel Burack,
Pantelis Antoniou,
Bill Garcia,
Peter Gordon,
Matthew Scherer
Publication year - 2020
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiaa142
Subject(s) - psychosocial , medicine , social work , syringe , hepatitis c , hepatitis , nursing , virology , intensive care medicine , psychiatry , economics , economic growth
Direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) is highly effective. However, people who inject drugs face significant barriers to DAA access.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom